Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS).
about
Immunohistochemical localization of phosphodiesterase 2A in multiple mammalian speciesKeratinocyte expression of calcitonin gene-related peptide β: implications for neuropathic and inflammatory pain mechanismsThe Role of Botulinum Toxin Type A in the Clinical Management of Refractory Anterior Knee PainSensory detection and responses to toxic gases: mechanisms, health effects, and countermeasures.Transient receptor potential channel polymorphisms are associated with the somatosensory function in neuropathic pain patientsComplex regional pain syndrome: a recent update.[Complex regional pain syndrome following distal fractures of the radius : Epidemiology, pathophysiological models, diagnostics and therapy].Efficacy of Noninvasive Stellate Ganglion Blockade Performed Using Physical Agent Modalities in Patients with Sympathetic Hyperactivity-Associated Disorders: A Systematic Review and Meta-AnalysisOrthopedic surgery and bone fracture pain are both significantly attenuated by sustained blockade of nerve growth factor.Chip-based immunoaffinity CE: application to the measurement of brain-derived neurotrophic factor in skin biopsiesThe conundrum of sensitization when recording from nociceptors.Complex interaction of sensory and motor signs and symptoms in chronic CRPS.Validation of proposed diagnostic criteria (the "Budapest Criteria") for Complex Regional Pain Syndrome.The use of ketamine in complex regional pain syndrome: possible mechanisms.Stem cells and other innovative intra-articular therapies for osteoarthritis: what does the future hold?Proteomic identification of altered cerebral proteins in the complex regional pain syndrome animal model.Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study.Somatosensory and vasomotor manifestations of individual and combined stimulation of TRPM8 and TRPA1 using topical L-menthol and trans-cinnamaldehyde in healthy volunteers.Vitamin D receptor and enzyme expression in dorsal root ganglia of adult female rats: modulation by ovarian hormones.Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: a randomized controlled trial.Botulinum toxin therapy for osteoarticular pain: an evidence-based reviewMorphological macrovascular alterations in complex regional pain syndrome type I demonstrated by increased intima-media thickness.Neuropeptides contribute to peripheral nociceptive sensitization by regulating interleukin-1β production in keratinocytesThermographic evaluation of hind paw skin temperature and functional recovery of locomotion after sciatic nerve crush in rats.Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers.Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome.New Concepts in Complex Regional Pain Syndrome.Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndromeAcute versus chronic phase mechanisms in a rat model of CRPS.Inflammation in complex regional pain syndrome: a systematic review and meta-analysisInflaming the brain: CRPS a model disease to understand neuroimmune interactions in chronic pain.Algodystrophy in major orthopaedic surgery.Oxidative stress in Complex Regional Pain Syndrome (CRPS): no systemically elevated levels of malondialdehyde, F2-isoprostanes and 8OHdG in a selected sample of patients.Neuroinflammation, neuroautoimmunity, and the co-morbidities of complex regional pain syndrome.Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndromeAcute and chronic phases of complex regional pain syndrome in mice are accompanied by distinct transcriptional changes in the spinal cord.Nonoperative treatment approach to knee osteoarthritis in the master athlete.Use of botulinum toxin in musculoskeletal pain.Complex regional pain syndromes: new pathophysiological concepts and therapies.Role of peripheral nerve fibres in acute and chronic inflammation in arthritis.
P2860
Q24337499-C1B07D5C-60E6-4FA0-815B-9BD4E6A6BD48Q24616045-F18F100F-018A-40CB-8243-507B04E1FE7CQ26797317-9456648C-532D-4067-B270-8A13F75EA9AAQ27693846-8859CA2D-A0AA-4FE6-8C01-8DFD9FEDF40AQ28741571-D82F372E-2B32-4D67-9CD5-4AB8FB6A565DQ30238767-76A1D52E-09EF-4D84-B25A-B0BAFA882B02Q30248635-F763D610-FCA8-4068-9105-7E3C9CE3B7D5Q30367590-D84981CF-BB36-478F-A8F3-C9BB86E95DB2Q30657180-4E2209AA-48C6-496D-AF90-A341EF2C8517Q33476951-03322E93-6914-417D-81A0-EE58BA84BCE6Q33787776-BB5D62B3-F9E2-4430-9510-0AEC3FC92370Q33895309-0035DA69-A9D4-4E9E-A432-530A142EA450Q34039009-A65D370D-22D6-497E-AA0B-D0B63AC71947Q34182127-C05D4560-D4A2-44E6-ADD3-DFE9F76AD9A7Q34253770-329690B9-F01F-47B2-AB47-6CD877156366Q34275621-1BAD4431-81F0-45C1-834A-CDB2AAA6A15AQ34315007-43743226-E1B4-4971-9549-E959D6CD618DQ34411838-2A53DC6A-A85F-4A0E-B225-FD4AE5DABF8BQ34420143-D63EE449-BA7C-43D8-A73B-906BB0D77C1FQ34479556-BD88DA21-CC99-4B7A-A869-63FA2BF924F5Q34554147-AEC1459D-4C74-4B07-A4ED-3B4B61A13285Q34577386-654C4E2A-9855-4EDD-A64E-9F35853B248EQ35068859-F5DA6FD9-C574-4D8F-8697-7E9EDEC25B16Q35141995-F3ABCA73-86CB-40AB-9C56-0B3BF86F3D73Q35162929-B09EEA20-B57D-4888-A2F6-73F086D67629Q35850819-C9BC20EF-6FA0-4803-88FA-A4CC2229BBE7Q36327294-D7678083-63A8-4F17-A659-EAC684721C0EQ36395889-EE9A14F6-1F9C-4077-9D2E-C4A9712769FCQ36480963-59402E8C-F36E-4E7F-8214-49D6660C9A57Q36659427-C2DEBCD1-C0DB-48D2-8BF8-BBA2B785FFC4Q36681040-B8D9F3E2-CE7D-4089-BFEA-82BEA4BEA6C8Q36800205-153ED62C-FD8E-48D3-A378-B0DA36A06E76Q36820521-51144F9B-3DC9-43EA-84D4-17D0E0277806Q36868585-9AB22156-25E8-4823-B67F-F8D8E683517DQ37020591-661F52C3-86BE-46A1-AC26-AE47830BECE0Q37116137-416335EE-B8DA-473A-A6E3-BED1D306EF13Q37417111-AC291361-35A8-43BB-9D13-15D4325EA451Q37671002-3DF7EC60-F678-4076-AD51-3709505E0353Q37697878-7518957B-C1D9-4AFD-AE67-465A24C6B276Q38059456-8A95B815-D056-44AF-9F18-FEFFA3804D52
P2860
Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS).
@en
Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS).
@nl
type
label
Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS).
@en
Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS).
@nl
prefLabel
Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS).
@en
Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS).
@nl
P1433
P1476
Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS).
@en
P2093
Frank Birklein
P304
P356
10.1016/J.NEULET.2008.03.081
P407
P577
2008-03-30T00:00:00Z